Carboplatin Injection — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Carboplatin Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Apr 28, 2023.

Shortage details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0703-4246-01
Dosage Form
Injection
Presentation
Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01)
Initial Posting
Apr 28, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.